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Edited by Julian SchroederAbstract Tomato Cf-9, a receptor-like protein (RLP), confers
resistance to races of the fungal pathogen Cladosporium fulvum
that express the Avr9 avirulence gene. CITRX (Cf-9-interacting
thioredoxin) was previously identiﬁed in a yeast two-hybrid
screen as a protein interacting with the cytoplasmic domain of
Cf-9 and shown to be a negative regulator of the cell death in-
duced after Cf-9/Avr9 interaction. ACIK1 is a Ser/Thr pro-
tein kinase that is speciﬁcally required for the Cf-9 and Cf-4
dependent defence response in tomato. In this paper we present
data suggesting that CITRX may act as an adaptor recruiting
the ACIK1 kinase to the cytoplasmic domain of Cf-9 upon elic-
itation with the Avr9 peptide. Interestingly, the catalytic activi-
ties of both CITRX and ACIK1 are not required for their
interaction.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Plant cells induce defence responses upon perception of
pathogen-derived molecules. General elicitors, such as bacte-
rial ﬂagellin, can activate resistance [1]. However, resistance
is often governed by a ‘gene-for-gene’ interaction [2], in which
plants carrying a resistance (R) gene speciﬁcally recognize a
pathogen carrying a corresponding avirulence (Avr) gene. R
gene-mediated resistance is typically accompanied by rapid cell
death at the site of infection called the hypersensitive response
(HR). Proteins encoded by R genes are divided into a few dif-
ferent classes based on their domain organisation and localisa-
tion within the cell [2].
Tomato Cf genes confer resistance to speciﬁc races of Clad-
osporium fulvum, a biotrophic fungus that causes leaf mould in
tomato, through recognition of Avr peptides that are secretedAbbreviations: RLP, receptor-like protein; RLK, receptor-like kinase;
eLRRs, extracellular leucine-rich repeats; Y2H, yeast two-hybrid;
HR, hypersensitive response; MBP, maltose binding protein; GST,
glutathione transferase; DSP, dithiobis(succinimidyl)propionate;
ONPG, o-nitrophenyl b-D-galactopyranoside
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doi:10.1016/j.febslet.2006.06.077into the leaf apoplast during infection. For example, the R
gene Cf-9 confers resistance to strains of C. fulvum that express
Avr9 [3].
Cf genes encode receptor-like proteins (RLPs), which are
type I transmembrane glycoproteins carrying extracellular
leucine-rich repeats (eLRRs), a transmembrane region, and
a short cytoplasmic domain that has no similarity to known
signalling domains. Apart from RLPs, the eLRR protein
class includes receptor-like kinases (RLKs), which, in addi-
tion to an extracellular LRR region and a transmembrane
domain, possess a cytoplasmic kinase domain. eLRR-conta-
ing proteins are quite abundant in plants with 56 eLRR-
RLPs and 216 eLRR-RLKs encoded in the Arabidopsis
genome [4,5]. In addition to Cf proteins, a function has been
assigned to several other eLRR-containing RLPs and RLKs.
Some RLPs, like Cf-9, RPP27 or Ve1, play a role in defence
against pathogens [3,6,7], while others function in meristem
development (CLV2) or distribution of stomata (TMM)
[8,9]. RLKs carrying eLRRs are also involved in various
physiological processes, such as defence response (FLS2,
Xa21), meristem development (CLV1), response to brassinos-
teroid hormones (BRI1, BAK1), nodulation (SYMRK), pol-
lination (LePRK) and others (reviewed in [10,11]). Several
eLRR RLPs and RLKs were found to interact with other
components of signalling complexes. For instance, BRI1
interacts with BAK1 [12,13], CLV1 is expected to interact
with CLV2 [8], and LePRK2 associates with LePRK1 [14].
Based on the examples mentioned above, it seems that many
plant signalling pathways involving eLRR proteins transduce
signals through induction of the RLK kinase activity. How-
ever, no RLK(s) required for the activation of the Cf-depen-
dent defence response have been identiﬁed so far. In this
paper we present evidence for physical association between
the cytoplasmic domain of Cf-9 and the Avr9/Cf-9 induced
kinase 1 (ACIK1). This physical association is mediated by
the Cf-9 interacting thioredoxin (CITRX). CITRX was iden-
tiﬁed as a result of a yeast two-hybrid screen carried out with
the C-terminal cytoplasmic domain of Cf-9 and was reported
to be a speciﬁc negative regulator of the cell death induced
through Cf-9 [15]. ACIK1 is a cytoplasmic Ser/Thr kinase
and its coding gene (ACRE-264) was originally identiﬁed as
an Avr9/Cf-9 rapidly elicited (ACRE) gene using cDNA-
AFLP analysis in Nicotiana tabacum cell cultures [16].
ACIK1 was found to be required for Cf-9/Avr9- and Cf-4/
Avr4-mediated HRs but not for the HR or resistance medi-
ated by other R/Avr systems, such as Pto/AvrPto, Rx/Potato
virus X, or N/Tobacco mosaic virus [17].blished by Elsevier B.V. All rights reserved.
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in which Avr9 perception by Cf-9 leads to activation of the
ACIK1 kinase that is recruited to the cytoplasmic domain of
Cf-9 by the CITRX thioredoxin serving as an adaptor protein.2. Materials and methods
2.1. Yeast two- and three-hybrid assays
For the experiments using the LexA-based yeast two-hybrid (Y2H)
system (Clontech) fusions between the LexA DNA binding domain
and either the full length LeACIK1, or its truncated versions (LeA-
CIK1Daa366–464, LeACIK1Daa1–84, LeACIK1Daa85–464, LeACIKaa85–365,
LeACIK1Daa1–365) were created by the PCR-ampliﬁcation of the corre-
sponding region from LeACIK1 cDNA (AF332960) and subsequentFig. 1. Cf-9C-term., LeCITRX and LeACIK1 interact in Y2H and Y3H syst
domains: N-terminal (N, aa1–84), kinase (K, aa85–365) and C-terminal (C, a
type LeCITRX and the truncated form with ﬁrst 64aa removed interact wi
domain. The intensity of interaction between LeCITRX and diﬀerent domain
with ONPG as substrate. (D) LeCITRX with both catalytic cysteines replaced
acids (LeCITRXDaa151–175) were tested against LeACIK1 in Y2H assays. (E) L
with Cf-9C-term.. (F) LeCITRXSGPS was compared to LeCITRXw.t. for its a
control. Experiments in (B, E) and (C, D and F) were done using GAL4 a
9Cterm. in the presence of LeCITRX in the Y3H system (yeast colonies grow
colonies stop growing on the –HIS medium supplemented with methionine if t
MET25 promoter. (I) A model illustrating interactions between Cf-9, CITRX
64 amino acids.cloning of PCR products into pGILDA bait vector. The LexA-fusion
of the kinase-inactive mutant LeACIK1D215A was constructed as de-
scribed above with the only diﬀerence that the D215A aa exchange
was introduced by a site-directed mutagenesis performed using overlap
extension PCR [18] to create a template for the cloning PCR. Prey con-
structs pB42AD:LeCITRXw.t. and pB42AD:LeCITRXDaa151–175 were
described previously [15]. pB42AD:AtTRX-x was created in the same
way as pB42AD:LeCITRXw.t. but in this case primers speciﬁc for
AtTRX-x cDNA (AAF15952) were used for the PCR. In order to cre-
ate pB42AD:LeCITRXSGPS, C98S and C101S aa exchanges were
introduced by site-directed mutagenesis [18]. The interactions were
tested in yeast strain EGY48 according to the manufacturer’s instruc-
tions (Clontech).
For the assays using GAL4-based Y2H system (Clontech) LeCI-
TRXw.t. and LeCITRXDaa1–64 were ampliﬁed by PCR and cloned into
the GAL4 BD-vector pBridge. pBridge:LeACIK1 was created by
subcloning LeACIK1 ORF from pGILDA:LeACIK1 into pBridge.ems. (A) LeACIK1 amino acid sequence can be subdivided into three
a366–464) domain. (B) LeACIK1 interacts with LeCITRX. Both wild-
th LeACIK1. (C) LeACIK1 interacts with LeCITRX through the N-
s of LeACIK1 was measured using a quantitative b-galactosidase assay
with serines (LeCITRXSGPS) and LeCITRX without the last 25 amino
eCITRXD1–64 was compared to LeCITRX w.t. for its ability to interact
bility to interact with Cf-9C-term.. AtTRX-x was used as the negative
nd LexA Y2H systems respectively. (G) LeACIK1 interacts with Cf-
n on a – HIS plate). (H) The DB:Cf-9C-term./LeCITRX/AD: LeACIK1
he linker gene (LeCITRX) is expressed from the methionine repressible
and ACIK1. The region of LeCITRX shown in blue represents the ﬁrst
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encoding the last 32 amino acids from pGILDA:Cf-9C-term. [15].
Fusions of LeCITRXw.t. and LeCITRXDaa1–84 with GAL4 AD were
created by PCR ampliﬁcation of corresponding regions of the cDNA.
The PCR products were cloned into the pGADT7 vector.
For the yeast three-hybrid (Y3H) assays, PCR-ampliﬁed LeCITRX
ORF was inserted into MCSII of pBridge:Cf-9C-term..
In the case of both GAL4 Y2H and Y3H systems the interactions
were tested in yeast strain AH109 according to the manufacturer’s
instructions (Clontech).
The quantitative b-galactosidase assay was performed with ONPG
(o-nitrophenyl b-D-galactopyranoside) as substrate according to the
protocol described in Clontech ‘‘Yeast Protocols Handbook’’.
The activity of b-galactosidase was estimated based on the OD420 of
the reaction mix normalised against the OD600 of the yeast culture.
Three yeast culture samples were processed for each interaction tested
and average values were calculated (Fig. 1C).
2.2. Construction of plasmids for the transient expression
pBin19g:LeCITRX construct [15] was used to express LeCITRX-
HA. To create a construct for the expression of GUS-HA, the GUS
(b-D-glucuronidase) gene from E. coli was ampliﬁed by PCR and
cloned into the pBin19g vector. LeACIK1-Myc was expressed using
a pSR78:LeACIK1 construct. pSR78 contains a cluster of 6 Myc se-
quences downstream of the XhoI site, under the control of 35S pro-
moter, in the pBin19 backbone [19]. The LeACIK1 gene was
ampliﬁed by PCR with primers carrying SalI sites and cloned into
the XhoI site of pSR78. To create the construct for the expression of
EDS1-Myc, the Arabidopsis EDS1 gene was ampliﬁed by PCR using
primers carrying ClaI (forward) and BamHI (reverse) sites and the di-
gested PCR product was ligated into pBin19d vector, which contains
an in-frame cluster of 6 Myc sequences for epitope-tagging down-
stream of the BamHI site, under the control of the 35S promoter, in
the pBin19 backbone [19].
2.3. Agrobacterium-mediated transient expression
Transient expression of proteins in Nicotiana benthamiana was per-
formed as described in [20] with some alterations. In all cases proteins
were co-expressed with the suppressor of silencing p19 [21] to boost the
protein expression level. Agrobacterium cultures were diluted to an
OD600 of 1 and then equal volumes of two cultures expressing proteins
of interest and the culture expressing p19 were pre-mixed before the
inﬁltration step. Leaf samples were collected 48 h post inoculation
(hpi).
2.4. Immunoprecipitation and immunoblotting
For co-immunoprecipitation experiments agroinﬁltrated N. benth-
amiana leaves (48 hpi) were inﬁltrated with 1.5 or 3 mM DSP
(dithio-bis(succinimidyl)propionate) protein cross-linker (Pierce).
After 30 min. the leaf tissue was frozen in liquid nitrogen. The co-Fig. 2. LeACIK1 and LeCITRX interact in planta. A, LeACIK1-Myc, but no
presence of 1.5 mM DSP protein cross-linker. B, LeACIK1 can be co-imm
presence of 3 mM DSP. In all cases proteins were transiently co-expressed iimmunoprecipitation experiments were performed as described in
[22] with some alterations: the concentration of DTT was reduced to
0.5 mM to stabilize the cross-linker and Nonidet P-40 was omitted
from the procedure. The Western blotting was performed with anti-
HA and anti-Myc HRP-conjugated monoclonal antibodies according
to the manufacturer’s instructions (Roche).
2.5. In vitro kinase assay
MBP-LeACIK1 was prepared as described in [17]. GST-LeCITRX
[15], GST-Pto and GST-Pti1K96N [23] were expressed in E. coli BL21
strain and subsequently puriﬁed using glutathione sepharose (Amer-
sham Pharmacia) according to the manufacturer’s instructions. In
the case of GST-tagged proteins the GST tag was removed by throm-
bin cleavage. The in vitro kinase assay was performed as described in
[17] using 0.5 lg recombinant protein kinase and 1.5 lg kinase sub-
strate in a 15 ll volume. Each kinase reaction was started by addition
of 15 ll reaction mix to yield a ﬁnal concentration of 10 mM MgCl2,
10 mM MnCl2, 1 mM CaCl2, 0.925 MBq (2.5 lCi) [c-
32P]ATP
(111TBq/mmol; NEN) and 50 lM ATP. After incubation for 30 min
at 30 C, the reaction was stopped by adding 15 ll of SDS loading
dye. Samples were loaded onto the same SDS–polyacrylamide gel.
After electrophoresis the gel was stained with Coomassie brilliant blue,
dried and subjected to autoradiography to detect incorporation of 32P
into the kinase substrates.3. Results
3.1. LeACIK1 interacts with LeCITRX in the Y2H system
ACIK1 was previously identiﬁed as a protein kinase specif-
ically required for the Cf-9/Avr9 induced defence response
[17]. We were interested in ﬁnding other protein interactors
of ACIK1 that would provide further clues about molecular
details of the Cf-9 signalling mechanism. We used the Y2H
system to test two ACRE genes, which are required for the
Cf9/Avr9 induced HR, ACRE-189 (ACF1, F-box protein)
[17] and ACRE-74 (CMPG1, U-box protein) [24], and
CITRX as an interactor of the cytoplasmic domain of Cf-9
[15]. As a result, an interaction was only detected between
LeCITRX and NtACIK1.The tomato ortholog of tobacco
ACIK1, LeACIK1, was also found to interact with LeCI-
TRX (Fig. 1B). We performed mapping of LeACIK1 and
LeCITRX domains that are involved in the interaction (Figs.
1A–D). The LeACIK1 amino acid sequence can be divided
into 3 parts: the central kinase domain (K, aa85–365) and
ﬂanking N-terminal (N, aa1–84) and C-terminal (C, aa366–t EDS1-Myc, can be co-immunoprecipitated with LeCITRX-HA in the
unoprecipitated with LeCITRX-HA, but not with GUS-HA, in the
n Nicotiana benthamiana leaves.
Fig. 3. LeCITRX is speciﬁcally phosphorylated by LeACIK1 in vitro.
All proteins used in this assay were expressed in E. coli BL21 cells and
subsequently puriﬁed using either glutathione sepharose (GST-tag) or
amylose resin (MBP-tag). Puriﬁed LeACIK1 and Pto kinases were
subjected to an in vitro kinase assay using [c-32P]ATP as a radioactive
label for LeCITRX (C) and Pti1K96N (P) substrates. After the kinase
reaction, the samples were separated on a SDS–polyacrylamide gel,
and the gel was dried and subjected to autoradiography. Panel (i)
shows signals produced due to phosphorylation of the substrates and
kinase autophosphorylation activity. Panel (ii) shows the Coomassie-
stained gel.
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b-galactosidase activity to assess the intensity of interaction
between diﬀerent domains of LeACIK1 and LeCITRX. In
each case the b-galactosidase activity was measured 3 times
and an average value was calculated (see Section 2). Data
presented in Fig. 1C show that the N-terminal domain of
LeACIK1 as well as the kinase inactive mutant LeACIK1D215A
interacted with LeCITRX with the intensity similar to LeA-
CIK1w.t.. For other LeACIK1 truncations the b-galactosidase
activity was close to the basal level. Surprisingly, the ‘‘NK’’
truncation did not show any interaction with LeCITRX
although it was well expressed in yeast (Fig. S1). Probably,
the kinase domain, in the absence of the C-terminal domain,
perturbs the interaction between the N-terminal domain of
LeACIK1 and LeCITRX. Based on the data presented, the
N-terminal domain of LeACIK1 is involved in the interac-
tion with LeCITRX. Furthermore, the kinase activity of
LeACIK1 does not seem to be essential for the interaction.
To test whether the reducing activity of LeCITRX is re-
quired for the interaction with LeACIK1, we replaced both
cysteines in the catalytic site of LeCITRX (CGPC) with serines
(SGPS). LeCITRXSGPS interacted with LeACIK1 as eﬃciently
as LeCITRXw.t. (Fig. 1D). We also tested LeCITRXSGPS side
by side with LeCITRXw.t. against the cytoplasmic domain of
Cf-9 (Cf-9C-term.). The data presented in Fig. 1F show that
LeCITRXw.t. and LeCITRXSGPS interact with Cf-9C-term.
equally well.
Therefore, it appears that the catalytic activity of LeCITRX
is not essential for interactions with either Cf-9 or LeACIK1.
AtTRX-x [15,25], a thioredoxin related to AtCITRX (Arabid-
opsis ortholog of LeCITRX), was used as a negative control in
this assay. AtTRX-x did not interact with Cf-9 (nor with LeA-
CIK1, data not shown), indicating that the interaction of Cf-9
with LeCITRX is speciﬁc.
In order to ﬁnd out which regions of the LeCITRX amino
acid sequence are required for interactions with LeACIK1 and
Cf-9C-term. we used two truncations: LeCITRXD1–64 and LeCI-
TRXD151–175. The former truncation interacted with LeACIK1
but not with Cf-9C-term. (Figs. 1B and E), while the latter one
interacted neither with LeACIK1 (Fig. 1D) nor with Cf-9C-term.
[15]. These results suggest that theN-terminal part of LeCITRX
(aa1–64) is essential for the interaction with the cytoplasmic
domain of Cf-9, while its C-terminal part (aa151–175) is essen-
tial for interactions with both Cf-9 and LeACIK1.
LeACIK1 did not interact with Cf-9C-term. in the Y2H sys-
tem (data not shown). We hypothesized this was because LeA-
CIK1 does not interact with Cf-9 directly but rather through
an adaptor protein. To test whether LeCITRX is this adaptor
protein, we used the yeast three-hybrid system (Y3H). In addi-
tion to the expression of AD and BD-fusions, the Y3H system
allows expression of a third protein. Data presented in Fig. 1G
show that the interaction between LeACIK1 and Cf-9C-term.
was established in the presence of LeCITRX, based on the
expression of the HIS3 reporter gene. Since LeCITRX was ex-
pressed from the MET25 methionine-repressible promoter, we
tested whether the Cf-9C-term./LeCITRX/LeACIK1 interaction
happens in the presence of methionine. Fig. 1H shows that Cf-
9C-term./LeCITRX/LeACIK1 yeast cells stopped growing on
–HIS medium supplemented with methionine conﬁrming that
the interaction between LeACIK1 and Cf-9C-term. is dependent
on LeCITRX.A model summarizing our Y2H and Y3H data are shown in
Fig. 1I. According to this model LeCITRX serves as an adap-
tor protein connecting the LeACIK1 kinase with the cytoplas-
mic domain of Cf-9.3.2. LeCITRX and LeACIK1 interact in planta
To examine whether LeACIK1 and LeCITRX also interact
in planta, we did a series of co-immunoprecipitations with
LeACIK1-Myc and LeCITRX-HA transiently expressed in
N. benthamiana leaves. We could detect a LeACIK1/LeCITRX
interaction by using the DSP protein cross-linker (Fig. 2).
Fig. 2A shows that LeACIK1-Myc, but not EDS1-Myc [26]
4240 V. Nekrasov et al. / FEBS Letters 580 (2006) 4236–4241used as a negative control, was co-immunoprecipitated with
LeCITRX-HA. In a similar experiment (Fig. 2B), LeACIK1-
Myc co-immunoprecipitated with LeCITRX-HA but not with
GUS-HA, which was used as a negative control. The co-immu-
noprecipitations shown in Figs. 2A and B were repeated two
and three times respectively with similar results.3.3. LeCITRX is phosphorylated by LeACIK1
Having obtained the evidence for the LeACIK1/LeCITRX
interaction, we hypothesized that LeCITRX may be a sub-
strate for LeACIK1. We therefore did an in vitro kinase assay
(Fig. 3). In this experiment we compared the eﬃciency of LeC-
ITRX phosphorylation by MBP-LeACIK1 and GST-Pto ki-
nases. We used kinaseinactive GST-Pti1K96N, a known
substrate of Pto [27], as a control. The panel (ii) in Fig. 3 shows
that MBP-LeACIK1 phosphorylated GST-LeCITRX (‘‘C’’)
much more eﬃciently than GST-Pti1K96N (‘‘P’’), while Pto
showed the opposite result. Both MBPLeACIK1 and GST-
Pto demonstrated autophosphorylation activity in vitro (panel
(i) in Fig. 3). The equal intensity of autophosphorylation
bands in lanes ‘‘P’’ and ‘‘C’’ in the case of both MBP-LeA-
CIK1 and GST-Pto indicates equal kinase activity used for
reactions with GST-LeCITRX and GST-Pti1K96N. The data
presented in Fig. 3 are from the same protein gel and from
the same exposure time. This experiment was repeated three
times with similar results.4. Discussion
In this paper we demonstrate that LeACIK1 kinase inter-
acts with LeCITRX thioredoxin, both in the Y2H system
and in planta. We also show, using the Y3H system, that
LeACIK1 interacts with the cytoplasmic domain of Cf-9 in
the presence of LeCITRX. Altogether these data suggest that
CITRX could serve as an adaptor recruiting ACIK1 kinase
to the cytoplasmic domain of Cf-9 during the Avr9-induced
defence response. CITRX was previously identiﬁed as an
interactor of the cytoplasmic domain of Cf-9 and shown to
be a negative regulator of the Cf-9/Avr9-induced defence re-
sponse [15]. Thioredoxins are ubiquitous disulﬁde reductases
that generally serve as electron donors for various enzymatic
redox reactions [28]. However, there are also a number of re-
ports on thioredoxins being involved in regulation of cellular
processes, such as immune response, proliferation and apop-
tosis due to the ability of some of these proteins to modulate
the activity of certain transcriptional factors (e.g. NF-jB), ki-
nases (e.g. ASK1) and enzymes with tumour suppressor
activity (e.g. PTEN) [29–32]. The self-incompatibility
response in Brassica species provides another example of a
kinase being regulated by a thioredoxin. In this case, the
S-locus receptor kinase (SRK), a member of the RLK super-
family, is inhibited by the THL1 thioredoxin in the absence
of a ligand [33]. We previously reported that CITRX is a
suppressor of the Cf-9/Avr9-induced HR [15]. Results of
the kinase assay (panel (i) in Fig. 3), however, indicate that
LeCITRX does not inhibit LeACIK1 autophosphorylation
activity in vitro. However, we cannot rule out that the
in vivo conditions may be crucial for the inhibitory eﬀect.
In all examples mentioned above the reducing activity of thi-
oredoxins was found to be essential for their regulatory func-tions. Interestingly, catalytically inactive mutant
LeCITRXSGPS interacted with both Cf-9 cytoplasmic domain
and LeACIK1 as eﬃciently as the wild-type (Figs. 1C and
D). In agreement with these results, the catalytic activity of
LeCITRX was found to be dispensable for the attenuation
of the Cf-9/Avr9-induced defence response (Susana Rivas
and Jonathan Jones, unpublished). A paradox remains, how-
ever, between the proposed role of CITRX as an adaptor for
ACIK1 and its function as a negative regulator of the Cf-9/
Avr9 induced defence response. As ACIK1 is a positive reg-
ulator of the Cf-9 dependent defence response [17], silencing
of the CITRX gene, according to the model (Fig. 1I), is ex-
pected to downregulate the defence response. The eﬀect of
CITRX silencing is, however, the opposite: the defence re-
sponse becomes upregulated [15]. One hypothesis that can
explain this phenomenon is that CITRX is the ACIK1 adap-
tor present in excess. Since it is in excess, the number of
CITRX molecules interacting with both Cf-9 and ACIK1 is
limited. When CITRX is overexpressed, the number of
CITRX molecules associated with both Cf-9 and ACIK1
goes down and this results in a negative eﬀect on the defence
response. The virus induced gene silencing (VIGS) is never
100% eﬃcient (around 80% in the case of tobacco rattle virus
induced VIGS in tomato [34]). Therefore, according to the
proposed model, when CITRX level decreases due to silenc-
ing, the number of CITRX molecules interacting both Cf-9
and ACIK1 increases and this results in upregulation of
the defence response.
An alternative model is that CITRX is a negative regulator
that at the same time serves as an adaptor for the ACIK1 ki-
nase. As it was mentioned above, the VIGS in tomato is
around 80% eﬃcient. Therefore, the remaining 20% of LeCI-
TRX in silenced tomato leaves may be still suﬃcient for it to
function as an adaptor for LeACIK1, while its repressor func-
tion is abolished. An excellent example of an adaptor protein,
which at the same time acts as a repressor of the signaling
mechanism, is Tollip (Toll-interacting protein). Tollip is in-
volved in the IL-1R (interleukin 1 receptor), TLR2 and
TLR4 (toll-like receptors 2 and 4) signalling in mammalian
cells [35,36]. Tollip forms a complex with the IRAK kinase
under resting conditions. Upon triggering of the signalling
mechanism, Tollip recruits IRAK to the activated receptor.
As in the case with CITRX, overexpression of Tollip attenu-
ated the signalling response, while silencing of its coding gene
gave the opposite eﬀect [36]. Tollip was shown to be a substrate
for IRAK and an inhibitor of its kinase activity at the same
time.
LeACIK1 is related to a subgroup of Arabidopsis RLKs
called receptor-like cytoplasmic kinases (RLCKs) VII [4,37].
Unlike RLKs, RLCKs lack a transmembrane domain. There-
fore, it is possible that, similarly to the Tollip adaptor protein
in the IL-1 and Toll-like receptor signalling, LeCITRX serves
as an adaptor recruiting LeACIK1 to the cytoplasmic domain
of Cf-9 receptor-like protein during early stages of the Cf-9/
Avr9-induced defence response.
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